Stevanato Group S.p.A. (NYSE:STVN – Free Report) – Equities researchers at KeyCorp issued their FY2027 EPS estimates for shares of Stevanato Group in a research note issued on Tuesday, November 3rd. KeyCorp analyst P. Knight forecasts that the company will post earnings of $0.70 per share for the year. The consensus estimate for Stevanato Group’s current full-year earnings is $0.67 per share.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing analysts’ consensus estimates of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The firm had revenue of €326.06 million during the quarter.
A number of other brokerages also recently commented on STVN. William Blair downgraded shares of Stevanato Group from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Deutsche Bank started coverage on Stevanato Group in a report on Wednesday, October 7th. They set a “hold” rating for the company. Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. UBS Group lowered their price objective on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Finally, Citigroup dropped their price objective on Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
Read Our Latest Research Report on Stevanato Group
Stevanato Group Price Performance
Stevanato Group stock opened at €14.33 on Friday. The stock has a market cap of $4.34 billion, a P/E ratio of 24.70, a price-to-earnings-growth ratio of 1.44 and a beta of 0.80. The company has a fifty day simple moving average of €19.23 and a 200-day simple moving average of €17.92. Stevanato Group has a 12-month low of €12.05 and a 12-month high of €24.01. The company has a current ratio of 1.73, a quick ratio of 1.19 and a debt-to-equity ratio of 0.22.
Insiders Place Their Bets
In related news, Director William J. Federici bought 20,000 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The shares were purchased at an average cost of €13.72 per share, with a total value of €274,400.00. Following the transaction, the director directly owned 46,991 shares of the company’s stock, valued at approximately €644,716.52. This represents a 74.10% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Donald E. Morel, Jr. bought 25,000 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The stock was bought at an average cost of €13.07 per share, for a total transaction of €326,750.00. Following the completion of the transaction, the director directly owned 62,424 shares in the company, valued at approximately €815,881.68. The trade was a 66.80% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.70% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Stevanato Group
A number of institutional investors and hedge funds have recently bought and sold shares of STVN. Wellington Management Group LLP acquired a new position in Stevanato Group in the second quarter valued at $22,621,000. Ranger Investment Management L.P. acquired a new stake in shares of Stevanato Group during the second quarter worth about $21,438,000. Cooper Investors PTY Ltd. lifted its holdings in shares of Stevanato Group by 4.4% in the 2nd quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company’s stock valued at $12,080,000 after purchasing an additional 28,265 shares during the last quarter. Schwartz Investment Counsel Inc. lifted its holdings in shares of Stevanato Group by 15.0% in the 3rd quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company’s stock valued at $13,871,000 after purchasing an additional 86,385 shares during the last quarter. Finally, Riverbridge Partners LLC lifted its holdings in shares of Stevanato Group by 4.2% in the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company’s stock valued at $13,132,000 after purchasing an additional 25,400 shares during the last quarter.
Stevanato Group Company Profile
Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.
Featured Stories
- Five stocks we like better than Stevanato Group
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
